- Home
- QNCX vs RCON Comparison
QNCX vs RCON Comparison
Compare QNCX & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- RCON
- Stock Information
- Founded
- QNCX 2012
- RCON 2007
- Country
- QNCX United States
- RCON China
- Employees
- QNCX N/A
- RCON N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- RCON Oilfield Services/Equipment
- Sector
- QNCX Health Care
- RCON Energy
- Exchange
- QNCX Nasdaq
- RCON Nasdaq
- Market Cap
- QNCX 100.4M
- RCON 86.1M
- IPO Year
- QNCX 2019
- RCON 2009
- Fundamental
- Price
- QNCX $1.98
- RCON $1.92
- Analyst Decision
- QNCX Strong Buy
- RCON
- Analyst Count
- QNCX 6
- RCON 0
- Target Price
- QNCX $8.00
- RCON N/A
- AVG Volume (30 Days)
- QNCX 431.7K
- RCON 22.6K
- Earning Date
- QNCX 11-12-2025
- RCON 10-14-2025
- Dividend Yield
- QNCX N/A
- RCON N/A
- EPS Growth
- QNCX N/A
- RCON N/A
- EPS
- QNCX N/A
- RCON N/A
- Revenue
- QNCX N/A
- RCON $9,252,775.00
- Revenue This Year
- QNCX N/A
- RCON N/A
- Revenue Next Year
- QNCX N/A
- RCON $12.17
- P/E Ratio
- QNCX N/A
- RCON N/A
- Revenue Growth
- QNCX N/A
- RCON N/A
- 52 Week Low
- QNCX $0.71
- RCON $1.40
- 52 Week High
- QNCX $2.45
- RCON $7.16
- Technical
- Relative Strength Index (RSI)
- QNCX 62.46
- RCON 44.00
- Support Level
- QNCX $1.82
- RCON $1.90
- Resistance Level
- QNCX $2.01
- RCON $2.07
- Average True Range (ATR)
- QNCX 0.16
- RCON 0.10
- MACD
- QNCX 0.03
- RCON 0.01
- Stochastic Oscillator
- QNCX 64.48
- RCON 25.81
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About RCON Recon Technology Ltd.
Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.